Maqdasy, S.* ; Lecoutre, S.* ; Renzi, G.* ; Frendo-Cumbo, S.* ; Rizo-Roca, D.* ; Moritz, T.* ; Juvany, M.* ; Hodek, O.* ; Gao, H.* ; Couchet, M.* ; Witting, M. ; Kerr, A.* ; Bergo, M.O.* ; Choudhury, R.P.* ; Aouadi, M.* ; Zierath, J.R.* ; Krook, A.* ; Mejhert, N.* ; Rydén, M.*
Impaired phosphocreatine metabolism in white adipocytes promotes inflammation.
Nat. Metab. 4, 190-202 (2022)
The mechanisms promoting disturbed white adipocyte function in obesity remain largely unclear. Herein, we integrate white adipose tissue (WAT) metabolomic and transcriptomic data from clinical cohorts and find that the WAT phosphocreatine/creatine ratio is increased and creatine kinase-B expression and activity is decreased in the obese state. In human in vitro and murine in vivo models, we demonstrate that decreased phosphocreatine metabolism in white adipocytes alters adenosine monophosphate-activated protein kinase activity via effects on adenosine triphosphate/adenosine diphosphate levels, independently of WAT beigeing. This disturbance promotes a pro-inflammatory profile characterized, in part, by increased chemokine (C-C motif) ligand 2 (CCL2) production. These data suggest that the phosphocreatine/creatine system links cellular energy shuttling with pro-inflammatory responses in human and murine white adipocytes. Our findings provide unexpected perspectives on the mechanisms driving WAT inflammation in obesity and may present avenues to target adipocyte dysfunction.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Activated Protein-kinase; Adipose-tissue; Creatine-kinase; Obesity; Ampk; Expression; Thermogenesis; Transport; Health; Target
Keywords plus
Language
english
Publication Year
2022
Prepublished in Year
HGF-reported in Year
2022
ISSN (print) / ISBN
2522-5812
e-ISSN
2522-5812
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 4,
Issue: 2,
Pages: 190-202
Article Number: ,
Supplement: ,
Series
Publisher
Springer
Publishing Place
London
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
30202 - Environmental Health
Research field(s)
Enabling and Novel Technologies
Environmental Sciences
PSP Element(s)
G-505700-001
G-504800-001
Grants
Margareta af Uggla's foundation
Swedish Research Council, KI infrastructure and Centre for Innovative Medicine
Novo Nordisk
Fondation Bettencourt Schueller
Societe Francophone du Diabete
Universite Clermont Auvergne
Strategic Research Programme in Diabetes at Karolinska Institutet
Stockholm County Council
Swedish Diabetes Foundation
Knut and Alice Wallenbergs Foundation
NovoNordisk Foundation
ERC-SyG SPHERES
Swedish Research Council
CIMED
Copyright
Erfassungsdatum
2022-05-04